Company Search:
Advanced Search
Sponsored Links
Nymox Pharmaceutical Corp Company Snapshot
Nymox Pharmaceutical Corp operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nymox Pharmaceutical Corp with three other pharmaceutical manufacturers in North America: AmpliPhi Biosciences Corp of the United States (2016 sales of $260,000.00 ), Sirona Biochem Corp (360,500.00 Canadian Dollars [US$271,665.59 ] ), and CEL-SCI Corporation which is based in the United States ($285,055.00 of which 100% was Pharmaceutical Products).

Sales Analysis. Sales fell dramatically in 2016: During the year ended December of 2016, sales at Nymox Pharmaceutical Corp were C$374,746.56 (US$282.40 thousand). This is a sharp decrease of 89.5% versus 2015, when the company's sales were C$3.56 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nymox Pharmaceutical Corp
  Stock Performance Chart for Nymox Pharmaceutical Corp
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): 5.09
(Figures in Canadian Dollars)
1 Week 0.9%   13 Weeks -2.0%  
4 Weeks 18.5%   52 Weeks 23.8%  
Nymox Pharmaceutical Corp Key Data:
  Ticker: NYMX Country: Canada
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 374,747
(Year Ending Jan 2017).
Employees: 4
  Currency: Canadian Dollars Market Cap: 256,792,484
  Fiscal Yr Ends: December Shares Outstanding: 50,449,696
  Share Type: Common Closely Held Shares: 18,568,775
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.